US Stock MarketDetailed Quotes
BETRF BETTERLIFE PHARMA INC
- 0.074460
- +0.002360+3.27%
15min DelayClose Apr 19 16:00 ET
8.64MMarket Cap-4964P/E (TTM)
0.074460High0.074460Low550Volume0.074460Open0.072100Pre Close40.95Turnover0.00%Turnover RatioLossP/E (Static)116.04MShares0.09410052wk High-1.31P/B7.88MFloat Cap0.03090052wk Low--Dividend TTM105.79MShs Float0.680000Historical High--Div YieldTTM0.00%Amplitude0.030900Historical Low0.074000Avg Price1Lot Size
BETTERLIFE PHARMA INC Key Stats
Quarterly+Annual
YOY
| (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | (Q3)Oct 31, 2022 | (Q2)Jul 31, 2022 | (Q1)Apr 30, 2022 | (FY)Jan 31, 2022 | (Q4)Jan 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 37.60%-395.87K | -43.05%-466.47K | -236.88%-1.35M | 86.58%-1.5M | 92.77%-140.76K | 70.22%-634.46K | 92.35%-326.1K | 85.95%-402.2K | -56.36%-11.2M | 26.76%-1.95M |
| Net income from continuing operations | 95.43%-213.74K | 8.66%-1.03M | 67.76%-963.67K | 22.92%-9.37M | 85.28%-579.76K | -111.94%-4.68M | 68.48%-1.13M | -22.31%-2.99M | 66.55%-12.16M | 85.68%-3.94M |
| Operating gains losses | -87.33%50.13K | -449.61%-71.59K | 812.62%288.17K | 679.32%395.06K | -177.60%-52.6K | 1,092.58%395.6K | -82.60%20.48K | 118.80%31.58K | 106.59%50.69K | 102.12%67.78K |
| Depreciation and amortization | --0 | --0 | --0 | -0.01%18.44K | -0.02%4.61K | 0.00%4.61K | 0.00%4.61K | 0.00%4.61K | -94.62%18.44K | -93.22%4.61K |
| Other non cash items | -115.40%-542.04K | -58.36%78.52K | -230.73%-93.3K | 215.89%3.07M | -161.85%-707.71K | 2,532.29%3.52M | 745.71%188.55K | 243.73%71.37K | -94.66%972.23K | -93.50%1.14M |
| Change In working capital | 1,156.44%197.44K | -1.83%322.02K | -132.56%-680.4K | 360.83%3.43M | 691.06%1.03M | -356.26%-18.69K | 131.75%328.02K | 595.99%2.09M | 14.75%-1.32M | 109.76%130.81K |
| -Change in receivables | 92.74%-901 | 470.68%23.92K | -105.95%-18.66K | 71.25%310.01K | 105.99%15.47K | -152.49%-12.4K | -123.13%-6.45K | -19.13%313.4K | 151.74%181.03K | 0.19%-258.02K |
| -Change in prepaid assets | -2,018.67%-77.4K | 5.53%112.33K | -217.07%-389.79K | 5,685.36%595.2K | 2.46%151.76K | -99.21%4.03K | 134.69%106.45K | 197.53%332.96K | 103.81%10.29K | 153.49%148.11K |
| -Change in payables and accrued expense | 2,772.15%275.74K | -18.53%185.77K | -118.85%-271.95K | 267.69%2.53M | 260.41%867.57K | 98.04%-10.32K | 130.23%228.03K | 408.74%1.44M | -63.12%-1.51M | 131.69%240.72K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 37.60%-395.87K | -43.05%-466.47K | -236.88%-1.35M | 86.58%-1.5M | 92.77%-140.76K | 70.22%-634.46K | 92.35%-326.1K | 85.95%-402.2K | -56.36%-11.2M | 26.76%-1.95M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | ||||||||
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net intangibles purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -35.09%427.4K | -13.47%280K | 538.30%1.59M | -88.11%1.34M | 67,939.87%104.1K | 658.45K | -96.07%323.59K | -91.69%249.75K | 174.68%11.23M | -99.99%153 |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -229.91%-130K | --0 |
| Net common stock issuance | -15.85%287.4K | --220K | --1.59M | -92.72%833.31K | 346,211.97%491.76K | --341.55K | --0 | --0 | 787.33%11.44M | --142 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | -55.82%140K | ---- | ---- | 751.14%502.58K | -3,524,300.00%-387.66K | --316.9K | 164.70%323.59K | -40.95%249.75K | ---77.18K | --11 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -35.09%427.4K | -13.47%280K | 538.30%1.59M | -88.11%1.34M | 67,939.87%104.1K | --658.45K | -96.07%323.59K | -91.69%249.75K | 174.68%11.23M | -99.99%153 |
| Net cash flow | ||||||||||
| Beginning cash position | 323.20%60.99K | 1,618.09%247.47K | -95.21%8.31K | 12.15%173.51K | -98.05%41.66K | -99.66%14.41K | -94.76%14.4K | 12.15%173.51K | -95.29%154.72K | 311.62%2.13M |
| Current changes in cash | 31.40%31.53K | -7,326.05%-186.47K | 256.91%239.2K | -645.99%-167.62K | 98.12%-36.66K | 101.13%23.99K | -100.06%-2.51K | -208.04%-152.45K | 100.98%30.7K | -437.58%-1.95M |
| Effect of exchange rate changes | -96.99%98 | -100.56%-14 | 99.44%-37 | 120.29%2.42K | 125.59%3.31K | -80.97%3.25K | -49.58%2.52K | 68.39%-6.66K | -160.14%-11.91K | -803.78%-12.92K |
| End cash Position | 122.34%92.62K | 323.20%60.99K | 1,618.09%247.47K | -95.21%8.31K | -95.21%8.31K | -98.05%41.66K | -99.66%14.41K | -94.76%14.4K | 12.15%173.51K | 12.15%173.51K |
| Free cash flow | 37.60%-395.87K | -43.05%-466.47K | -236.88%-1.35M | 86.58%-1.5M | 92.77%-140.76K | 70.22%-634.46K | 92.35%-326.1K | 85.95%-402.2K | -54.28%-11.2M | 26.72%-1.95M |
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg